Document Detail


Obesity-related hypertension: epidemiology, pathophysiology, and clinical management.
MedLine Citation:
PMID:  20706196     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The prevalence of obesity, including childhood obesity, is increasing worldwide. Weight gain is associated with increases in arterial pressure, and it has been estimated that 60-70% of hypertension in adults is attributable to adiposity. Centrally located body fat, associated with insulin resistance and dyslipidemia, is a more potent determinant of blood pressure elevation than peripheral body fat. Obesity-related hypertension may be a distinct hypertensive phenotype with distinct genetic determinants. Mechanisms of obesity-related hypertension include insulin resistance, sodium retention, increased sympathetic nervous system activity, activation of renin-angiotensin-aldosterone, and altered vascular function. In overweight individuals, weight loss results in a reduction of blood pressure, however, this effect may be attenuated in the long term. An increasing number of community-based programs (including school programs and worksite programs) are being developed for the prevention and treatment of obesity. Assessment and treatment of the obese hypertensive patient should address overall cardiovascular disease (CVD) risk. There are no compelling clinical trial data to indicate that any one class of antihypertensive agents is superior to others, and in general the principles of pharmacotherapy for obese hypertensive patients are not different from nonobese patients. Future research directions might include: (i) development of effective, culturally sensitive strategies for the prevention and treatment of obesity; (ii) clinical trials to identify the most effective drug therapies for reducing CVD in obese, hypertensive patients; (iii) continued search for the genetic determinants of the obese, hypertensive phenotype.
Authors:
Theodore A Kotchen
Related Documents :
16371486 - Graded associations between cardiorespiratory fitness, fatness, and blood pressure in c...
10456266 - Weight change, ideal weight and hypertension.
15943826 - Morning cortisol does not mediate the association of size at birth with blood pressure ...
8640036 - The relationship between the intrauterine environment and blood pressure in 3-year-old ...
2018326 - Assessment of the use of disposable skin staplers in bowel anastomoses to reduce laparo...
8806916 - Airway closure and reopening assessed by the alveolar capsule oscillation technique.
Publication Detail:
Type:  Journal Article     Date:  2010-08-12
Journal Detail:
Title:  American journal of hypertension     Volume:  23     ISSN:  1941-7225     ISO Abbreviation:  Am. J. Hypertens.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-19     Completed Date:  2011-01-31     Revised Date:  2011-06-30    
Medline Journal Info:
Nlm Unique ID:  8803676     Medline TA:  Am J Hypertens     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1170-8     Citation Subset:  IM    
Affiliation:
Department of Medicine, Medical College of Wisconsin, Milwaukee, USA. tkotchen@mcw.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipokines / physiology
Blood Pressure / physiology
Humans
Hypertension* / epidemiology,  physiopathology,  therapy
Insulin Resistance / physiology
Obesity* / epidemiology,  physiopathology,  therapy
Prevalence
Chemical
Reg. No./Substance:
0/Adipokines

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
Next Document:  Vascular structure and oxidative stress in salt-loaded spontaneously hypertensive rats: effects of l...